1. Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation. (11th June 2020) Authors: Schuck, Edgar; Ferry, Jim; Gidal, Barry; Hussein, Ziad Journal: Acta neurologica Scandinavica Issue: Volume 142:Number 2(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Issue 8 (August 2021) Authors: Torrico, Faustino; Gascón, Joaquim; Barreira, Fabiana; Blum, Bethania; Almeida, Igor C; Alonso-Vega, Cristina; Barboza, Tayná; Bilbe, Graeme; Correia, Erika; Garcia, Wilson; Ortiz, Lourdes; Parrado, Rudy; Ramirez, Juan Carlos; Ribeiro, Isabela; Strub-Wourgaft, Nathalie; Vaillant, Michel; Sosa-Est... Journal: Lancet infectious diseases Issue: Volume 21:Issue 8(2021) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Perampanel and pregnancy. (5th March 2021) Authors: Vazquez, Blanca; Tomson, Torbjörn; Dobrinsky, Cindy; Schuck, Edgar; O'Brien, Terence J. Journal: Epilepsia Issue: Volume 62:issue 3(2021) Page Start: 698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs. (20th February 2018) Authors: Nomoto, Maiko; Zamora, Cynthia A.; Schuck, Edgar; Boyd, Peter; Chang, Min‐Kun; Aluri, Jagadeesh; Siu, Y. Amy; Lai, W. George; Yasuda, Sanae; Ferry, Jim; Rege, Bhaskar Journal: British journal of clinical pharmacology Issue: Volume 84:Number 5(2018:Nov.) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E2027: Confirmation of Target Engagement and Selection of Phase 2 Dose in Dementia With Lewy Bodies Trial. (9th July 2022) Authors: Landry, Ishani S.; Aluri, Jagadeesh; Schuck, Edgar; Ino, Mitsuhiro; Horie, Kanta; Boyd, Peter; Reyderman, Larisa; Lai, Robert Journal: Alzheimer disease and associated disorders Issue: Volume 36:Number 3(2022) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective. Issue 1 (2nd February 2018) Authors: Shebley, Mohamad; Sandhu, Punam; Emami Riedmaier, Arian; Jamei, Masoud; Narayanan, Rangaraj; Patel, Aarti; Peters, Sheila Annie; Reddy, Venkatesh Pilla; Zheng, Ming; de Zwart, Loeckie; Beneton, Maud; Bouzom, Francois; Chen, Jun; Chen, Yuan; Cleary, Yumi; Collins, Christiane; Dickinson, Gemma L.; ... Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 1(2018) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors. (1st May 2021) Authors: Ueno, Takashi; Miyajima, Yukiko; Landry, Ishani; Lalovic, Bojan; Schuck, Edgar Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 5(2021) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape. (1st February 2018) Authors: Nijsen, Marjoleen J.M.A.; Wu, Fan; Bansal, Loveleena; Bradshaw‐Pierce, Erica; Chan, Jason R.; Liederer, Bianca M.; Mettetal, Jerome T.; Schroeder, Patricia; Schuck, Edgar; Tsai, Alice; Xu, Christine; Chimalakonda, Anjaneya; Le, Kha; Penney, Mark; Topp, Brian; Yamada, Akihiro; Spilker, Mary E. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 3(2018) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges. (24th November 2019) Authors: Geerts, Hugo; Wikswo, John; van der Graaf, Piet H.; Bai, Jane P.F.; Gaiteri, Chris; Bennett, David; Swalley, Susanne E.; Schuck, Edgar; Kaddurah‐Daouk, Rima; Tsaioun, Katya; Pelleymounter, Mary Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 1(2020) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model. (7th August 2019) Authors: Chen, Yuan; Cabalu, Tamara D.; Callegari, Ernesto; Einolf, Heidi; Liu, Lichuan; Parrott, Neil; Peters, Sheila Annie; Schuck, Edgar; Sharma, Pradeep; Tracey, Helen; Upreti, Vijay V.; Zheng, Ming; Zhu, Andy Z.X.; Hall, Stephen D. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 9(2019) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗